Ticker: AGLE

Company: Aeglea BioTherapeutics, Inc.

Person: Fairmount Funds Management LLC, director

Transaction date: June 23, 2026

Reporting date: June 23, 2026

Average share price: 99.46456475583865

Sold 4018101.0 shares for 399658667.11